Peer-reviewed journal articles (47)
1.
Bodac, A., Mayet, A., Rana, S., Pascual, J., Bowler, A. D., Roh, V., Fournier, N., Craciun, L., Demetter, P., Radtke, F., & Meylan, E. (2024). Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth. EMBO molecular medicine, 16(1), 158-184. doi:10.1038/s44321-023-00013-x2.
Davenne, T., Percier, P., Larbanoix, L., Moser, M., Leo, O., Meylan, E., Goriely, S., GĂ©rard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosiere, R. (2022). Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. Journal of controlled release, 353, 317-326. doi:10.1016/j.jconrel.2022.11.0553.
Quail, D., Amulic, B., Aziz, M., Barnes, B., Eruslanov, E., Fridlender, Z., Goodridge, H., Granot, Z., Hidalgo, A., Huttenlocher, A., Kaplan, M. J., Malanchi, I., Merghoub, T., Meylan, E., Mittal, V., Pittet, M. J., Rubio-Ponce, A., Udalova, I., van den Berg, T. K., Wagner, D. D., Wang, P., Zychlinsky, A., de Visser, K. E., Egeblad, M., & Kubes, P. (2022). Neutrophil phenotypes and functions in cancer: A consensus statement. The Journal of experimental medicine, 219(6). doi:10.1084/jem.202200114.
Pinjusic, K., Dubey, O. A., Egorova, O., Nassiri, S., Meylan, E., Faget, J., & Constam, D. B. (2022). Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. Journal for ImmunoTherapy of Cancer, 10(5), e004533. doi:10.1136/jitc-2022-0045336.
Martinez-Usatorre, A., Kadioglu, E., Boivin, G., Cianciaruso, C., Guichard, A., Torchia, B., Zangger, N., Nassiri, S., Keklikoglou, I., Schmittnaegel, M., Ries, C. H., Meylan, E., & De Palma, M. (2021). Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models. Science Translational Medicine, 13(606). doi:10.1126/scitranslmed.abd16167.
Faget, J., Peters, S., Quantin, X., Meylan, E., & Bonnefoy, N. (2021). Neutrophils in the era of immune checkpoint blockade. Journal for ImmunoTherapy of Cancer, 9(7), e002242. doi:10.1136/jitc-2020-0022428.
Ancey, P.-B., Contat, C., Boivin, G., Sabatino, S., Pascual, J., Zangger, N., Perentes, J. Y., Peters, S., Abel, D., Kirsch, D., Rathmell, J., Vozenin, M.-C., & Meylan, E. (2021). GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy. Cancer research, 81(9), 2345-2357. doi:10.1158/0008-5472.CAN-20-28709.
Boivin, G., Ancey, P.-B., Vuillefroy de Silly, R., Kalambaden, P., Contat, C., Petit, B., Ollivier, J., Bourhis, J., Meylan, E., & Vozenin, M.-C. (2021). Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapy. Oncoimmunology, 10(1). doi:10.1080/2162402X.2021.187659710.
Boivin, G., Faget, J., Ancey, P.-B., Gkasti, A., Mussard, J., Engblom, C., Pfirschke, C., Contat, C., Pascual, J., Vazquez, J., Bendriss-Vermare, N., Caux, C., Vozenin, M.-C., Pittet, M., Gunzer, M., & Meylan, E. (2020). Durable and controlled depletion of neutrophils in mice. Nature communications, 11(1). doi:10.1038/s41467-020-16596-911.
Cavin, S., Gkasti, A., Faget, J., Hao, Y., Letovanec, I., Reichenbach, M., Gonzalez, M., Krueger, T., Dyson, P., Meylan, E., & Perentes, J. Y. (2020). Low-dose photodynamic therapy promotes a cytotoxic immunological response in a murine model of pleural mesothelioma. European journal of cardio-thoracic surgery, 58(4), 783-791. doi:10.1093/ejcts/ezaa14512.
Pfirschke, C., Engblom, C., Gungabeesoon, J., Lin, Y., Rickelt, S., Zilionis, R., Messemaker, M., Siwicki, M., Gerhard, G. M., Kohl, A., Meylan, E., Weissleder, R., Klein, A. M., & Pittet, M. (2020). Tumor-Promoting Ly-6G+ SiglecFhigh Cells Are Mature and Long-Lived Neutrophils. Cell reports, 32(12). doi:10.1016/j.celrep.2020.108164